MOZARNIS Trademark

Trademark Overview

On Friday, April 16, 2010, a trademark application was filed for MOZARNIS with the United States Patent and Trademark Office. The USPTO has given the MOZARNIS trademark a serial number of 85015767. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 2, 2013. This trademark is owned by Glaxo Group Limited. The MOZARNIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
mozarnis

General Information

Serial Number85015767
Word MarkMOZARNIS
Filing DateFriday, April 16, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 2, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 31, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 21, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, December 2, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 2, 2013ABANDONMENT - NO USE STATEMENT FILED
Thursday, April 11, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 10, 2013EXTENSION 5 GRANTED
Tuesday, April 9, 2013EXTENSION 5 FILED
Tuesday, April 9, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 25, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 25, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 12, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 11, 2012EXTENSION 4 GRANTED
Wednesday, October 10, 2012EXTENSION 4 FILED
Wednesday, October 10, 2012TEAS EXTENSION RECEIVED
Tuesday, May 22, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 21, 2012EXTENSION 3 GRANTED
Wednesday, April 4, 2012EXTENSION 3 FILED
Wednesday, April 4, 2012TEAS EXTENSION RECEIVED
Friday, October 14, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 13, 2011EXTENSION 2 GRANTED
Wednesday, October 12, 2011EXTENSION 2 FILED
Wednesday, October 12, 2011TEAS EXTENSION RECEIVED
Tuesday, March 29, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, March 26, 2011EXTENSION 1 GRANTED
Tuesday, March 15, 2011EXTENSION 1 FILED
Saturday, March 26, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 15, 2011TEAS EXTENSION RECEIVED
Tuesday, October 26, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 31, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 31, 2010PUBLISHED FOR OPPOSITION
Thursday, July 29, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, July 29, 2010ASSIGNED TO LIE
Wednesday, July 14, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 13, 2010ASSIGNED TO EXAMINER
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 21, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 20, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

mozarnis pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic